Skip to main content
Premium Trial:

Request an Annual Quote

Mayo, Univ. of Illinois Form Research Alliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Mayo Clinic and the University of Illinois have formed a strategic alliance to promote a "broad spectrum of collaborative research, development of new technologies and clinical tools, and design and implementation of novel education programs," the Mayo Clinic announced today.

A formal agreement was recently signed that provides a framework for broad cooperation in personalized medicine. Integration efforts will focus on three areas — basic, translational, and clinical research; bioengineering, particularly for point-of-care diagnostics; and development of tools and methods in computational biology and medicine.

Terms of the deal were not disclosed.

Initially, the alliance's projects will focus on genomics, the microbiome, bioinformatics, and other computational science, including the use of petascale computing, imaging, nanotechnology, and tissue engineering, the Mayo Clinic said. It added that several research projects are underway. Bilateral educational programs in engineering, computational medicine, nanotechnology, genomics innovation, and entrepreneurism are also being planned.

A steering committee is being formed to oversee the alliance, and all projects will require joint collaboration.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.